In the lower grade glioma dataset, we found that a poorer prognosis of patients correlated with low expression of HAR1A and HAR1B (Fig 2A and 2B), and with high expression of REST (Fig 2C). This evidence concerns the gene HAR1A and central nervous system cancer.